Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:00:58 EDT Tue 25 Mar 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for U:DVAX from 2024-03-26 to 2025-03-25 - 23 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-03-10 08:00U:DVAXNews ReleaseDeep Track Capital Sends Letter to Dynavax Technologies' Board of Directors
2025-03-06 06:00U:DVAXNews ReleaseDynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
2025-02-25 16:10U:DVAXNews ReleaseDynavax to Participate in Upcoming Investor Conferences
2025-02-20 16:01U:DVAXNews ReleaseDynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
2025-02-19 16:52U:DVAXNews ReleaseDynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
2025-02-19 09:00U:DVAXNews ReleaseDeep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting
2025-02-06 17:42U:DVAXNews ReleaseDynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025
2025-01-27 06:00U:DVAXNews ReleaseDynavax Advances Board Refreshment Program
2025-01-13 09:00U:DVAXNews ReleaseDynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
2024-11-26 16:05U:DVAXNews ReleaseDynavax to Present at the 7th Annual Evercore HealthCONx Conference
2024-11-11 08:00U:DVAXNews ReleaseDynavax Announces $100 Million Accelerated Share Repurchase Program
2024-11-07 16:02U:DVAXNews ReleaseDynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
2024-11-07 16:01U:DVAXNews ReleaseDynavax Announces $200 Million Share Repurchase Program
2024-10-29 08:30U:DVAXNews ReleaseDynavax Adopts Limited-Duration Stockholder Rights Plan
2024-10-24 16:10U:DVAXNews ReleaseDynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
2024-09-05 08:30U:DVAXNews ReleaseLantheus Appoints Julie Eastland as New Board Member
2024-08-06 16:01U:DVAXNews ReleaseDynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates
2024-07-23 16:00U:DVAXNews ReleaseDynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
2024-06-27 16:09U:DVAXNews ReleaseDynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program
2024-05-28 16:15U:DVAXNews ReleaseDynavax to Present at Upcoming Investor Conferences
2024-05-14 08:30U:DVAXNews ReleaseDynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B(TM) Regimen for Adults on Hemodialysis in the U.S.
2024-05-08 16:01U:DVAXNews ReleaseDynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
2024-04-24 16:05U:DVAXNews ReleaseDynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024